Difference between revisions of "Valganciclovir (Valcyte)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "[[Category:Drugs FDA" to "[[Category:FDA") |
m (→Also known as) |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
Antiviral with particular activity against cytomegalovirus (CMV). | Antiviral with particular activity against cytomegalovirus (CMV). | ||
| + | |||
| + | ==Also known as== | ||
| + | *'''Brand names:''' Cytomega, VagaCyte, Valcyclovir, Valcyte, Valgan, Valixa, Valnov, Virolfi, V-Gavir | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
[[Category:Oral medications]] | [[Category:Oral medications]] | ||
| − | [[Category: | + | [[Category:Viral DNA synthesis inhibitors]] |
| − | |||
[[Category:FDA approved in 2001]] | [[Category:FDA approved in 2001]] | ||
Latest revision as of 18:20, 27 February 2020
Antiviral with particular activity against cytomegalovirus (CMV).
Also known as
- Brand names: Cytomega, VagaCyte, Valcyclovir, Valcyte, Valgan, Valixa, Valnov, Virolfi, V-Gavir